"Pharmaceutical officials say they expect the virus will linger, morphing from a pandemic into a perennial endemic. And as Covid-19 mutations continue to spread and booster shots may be required on a regular basis, leaders from the three companies are enthusiastic about cashing in. 'As this shifts from pandemic to endemic, we think there’s an opportunity here for us,' said Frank D’Amelio, the chief financial officer for Pfizer, at a conference.
"The vaccines are already poised to be some of the most lucrative drugs of all time. The companies are expecting to bring in billions in profit this year alone, and all the major drugmakers with approved coronavirus vaccines received investments and backorders from government agencies."
"Pharmaceutical officials say they expect the virus will linger, morphing from a pandemic into a perennial endemic. And as Covid-19 mutations continue to spread and booster shots may be required on a regular basis, leaders from the three companies are enthusiastic about cashing in. 'As this shifts from pandemic to endemic, we think there’s an opportunity here for us,' said Frank D’Amelio, the chief financial officer for Pfizer, at a conference.
"The vaccines are already poised to be some of the most lucrative drugs of all time. The companies are expecting to bring in billions in profit this year alone, and all the major drugmakers with approved coronavirus vaccines received investments and backorders from government agencies."
So it's going be another yearly flu shot.
Nevermind helping people not be diabetic and at risk of dying from covid. No money there